Trammell Crow Company has announced that two tenants at Fulton Labs, the firm’s 725,000-square-foot, two-building life science campus in Chicago, signed leases to expand their footprint within the portfolio. The Chan Zuckerberg Biohub Chicago (CZ Biohub Chicago), a biomedical research institute launched by Priscilla Chan and Mark Zuckerberg's Chan Zuckerberg Initiative, signed a lease for approximately 28,200 square feet at 400 N. Aberdeen. On the same floor, Portal Innovations, an existing Fulton Labs tenant and venture accelerator, signed a lease to grow its platform at the Fulton Labs campus by 6,000 square feet to 55,000 square feet.
Upon initially signing a lease earlier this year at 1375 W. Fulton, CZ Biohub Chicago realized the immediate need for additional space. With no further room for expansion at 1375 W. Fulton, the Biohub will instead be moving into a new turn-key space at 400 N. Aberdeen in Q1 2024 and will temporarily occupy space in a Science-Ready Lab Suite at 1375 W. Fulton. CZ Biohub’s and Portal’s space at 400 N. Aberdeen will be custom delivered, designed by ESG Architects, with lab planning by CRB Group, and construction completed by Power Construction.
“The state-of-the-art lab and administrative space offered at 400 North Aberdeen gives us much-needed flexibility as we rapidly ramp up our research operations,” said Shana Kelley, president of CZ Biohub Chicago and the Neena B. Schwartz Professor of Chemistry and Biomedical Engineering at Northwestern University.
In its new space at 400 N. Aberdeen which is a floor below its existing labs, Portal Innovations – Chicago’s preeminent venture development engine that invests financial, physical and human capital to fuel life sciences breakthroughs – will collaborate with CZ Biohub Chicago to advance their common goal of fostering innovation in the life sciences industry.
The Fulton Labs Campus, represented by Dan Lyne, Executive Vice President, Global Health & Life Sciences at CBRE, includes 1375 W. Fulton -- which spans 300,000 square feet and features a Science-Ready Lab Suites program-- and 400 N. Aberdeen -- 425,000 square feet. Other tenants at the campus include Xeris Biopharma, Charles River Laboratories, Vanqua Bio, Talis Biomedical, Dimension Inx, and Celadyne Technologies.